07:00 , Apr 11, 2011 |  BC Week In Review  |  Financial News

Calyx Chemicals and Pharmaceuticals Ltd. proposes IPO

Calyx Chemicals and Pharmaceuticals Ltd. , Maharashtra, India   Business: Biomanufacturing   Date announced: 3/24/11   Type: IPO   To be raised: TBD   Shares: 68.3 million   Price: TBD   Underwriters: PL Capital Markets;...
07:00 , Apr 19, 2004 |  BC Extra  |  Company News

Bayhill names Schwartz CEO

Autoimmune company Bayhill (Palo Alto, Calif.) hired Mark Schwartz as president, CEO and a director. Schwartz formerly was president and CEO of inflammatory disease company Calyx (Hayward, Calif.). He replaces John Walker, who will remain...
08:00 , Jan 28, 2002 |  BioCentury  |  Finance

U.S. & Canadian IPO candidates

U.S. & Canadian IPO candidates Company Money raised since 1/1/00 Business Acorda (U.S.) $39.7M Neurological Achillion (U.S.) $65.0M Infectious diseases Altus (U.S.) $50.0M Chemistry, proteomics Calyx (U.S.) $30.0M Metabolic, autoimmune/inflammation CancerVax (U.S.) $30.0M Cancer Discovery...
08:00 , Jan 14, 2002 |  BioCentury  |  Finance

2002 Financial Markets Preview: Repricing the venture space

Life science venture capital firms raised record money last year, but some later stage companies are having difficulty raising equity because the valuations from their last round - priced in the waning days of the...
08:00 , Dec 10, 2001 |  BC Week In Review  |  Company News

Calyx board of directors update

Calyx Therapeutics Inc., Hayward, Calif.   Business: Metabolic, Autoimmune/Inflammation   Appointed: Lou Bock, managing director at BA Venture Partners; and Charles Hsu, general partner at Walden International  ...
08:00 , Dec 10, 2001 |  BioCentury  |  Finance

Stocking stuffers

Pre-holiday fundraisers look to be having a jolly time, as debt and equity deals topped $1.6 billion in the first week of December. And in keeping with the season, some companies - much like most...
08:00 , Dec 10, 2001 |  BioCentury  |  Finance

Stocking stuffers

Pre-holiday fundraisers look to be having a jolly time, as debt and equity deals topped $1.6 billion in the first week of December. And in keeping with the season, some companies - much like most...
08:00 , Dec 5, 2001 |  BC Extra  |  Financial News

Calyx raises $30 million

Calyx (Hayward, Calif.) raised $30 million in a private round through BA Venture Partners; Walden; A.M Pappas; U.S. Venture Partners; ABS Ventures; and Morgenthaler. The company is developing small molecules for diabetes and inflammatory conditions....
07:00 , May 21, 2001 |  BC Week In Review  |  Company News

Calyx management update

Calyx Therapeutics Inc., Hayward, Calif.   Business: Metabolic, Autoimmune/Inflammation   Hired: Mark Schwartz as president, CEO and a director, formerly chief commercial officer at Trega BioSciences Inc.; he replaces Somesh Sharma, who will remain CSO...
07:00 , May 14, 2001 |  BC Extra  |  Company News

Calyx appoints Schwartz president and CEO

Mark Schwartz was named president and CEO of Calyx . Prior to Calyx , he was chief commercial officer at Trega BioSciences, which was acquired by Lion Bioscience (LEON; NMarkt:LIO) in March. Calyx (Hayward, Calif.)...